Dear Editor,

Obesity is known to be an important public health problem due to the globalization of its risk factors and exponential increase in its consequences \[[@bib0005]\]. Obesity is considered as a main risk factor for developing cerebrovascular disease \[[@bib0010]\]. The increase in available carbohydrate-rich processed foods has contributed to obesity being catalogued nowadays as a pandemic illness. Obesity is defined as a multifactorial and chronic body mass index is established in (BMI)\> 30 kg / m^2^. The increasing incorporation of foods with high caloric content has contributed to the positive balance and weight gain for the coming years. In regulating the body\'s energy balance, adipocytes express a series of substances (enzymes, growth factors, cytokine). Two types of adipose tissue are found in humans \[[@bib0015]\]. White adipose tissue (WAT) whose function is reserve and brown adipose tissue (BAT) that participates in energy expenditure.

Early studies in obese patients, showed an increased risk of developing complications being hospitalized because of its multiple comorbidities. However, recent studies suggest that severely obese patients have mortality rates equal to or lower than severe non-obese patients, so it is worth clarifying the mechanisms by which these results are obtained \[[@bib0020]\]. In patients who develop ischemic stroke, a prevalence of obesity of at least 74 % has been reported and, although obesity increases cardiovascular risk and mortality in general, contradictory results have also been found in terms of mortality and involvement of Obese patients with ischemic infarcts, when evidencing the paradox of obesity in some studies.

The new SARS-CoV-2 coronavirus represents a new challenge for neurologists \[[@bib0020]\]. The potential invader to the nervous system of this virus belonging to beta coronaviruses and that is easily transmitted by secretions or direct contact, the number of patients is greater \[[@bib0025],[@bib0030]\]. Furthermore, in some studies TIA (Transient ischemic attack) or stroke have been reported as first clinical manifestation of covid19 \[[@bib0035]\]. In China, the initial epicenter of the pandemic, reports of neurological compromise were made, which have continued to be reported worldwide \[[@bib0025]\]. Vascular ischemic events play an important role in the pathophysiology of the disease. The increase risk of cerebrovascular disease is believed to be due to the preliminary evidence of hypercoagulopathy, which is indirectly showed by the increase in D-dimer in patients with Covid 19 infection \[[@bib0035]\].
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